Amneal Pharmaceuticals, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Amneal Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -1.28K %, a 14372% decline year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Return On Equity for 2023 was -69 %, a 38.9% increase from 2022.
  • Amneal Pharmaceuticals, Inc. annual Return On Equity for 2022 was -113 %, a 3332% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Return On Equity for 2021 was 3.49 %, a 81.1% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -69 +43.9 +38.9% Jan 1, 2023 Dec 31, 2023
2022 -113 -116 -3332% Jan 1, 2022 Dec 31, 2022
2021 3.49 -15 -81.1% Jan 1, 2021 Dec 31, 2021
2020 18.5 +124 Jan 1, 2020 Dec 31, 2020
2019 -105 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.